ArticlemAbs

A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy.

Gerhard Frey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.